Logan Capital Management Inc Astrazeneca PLC Transaction History
Logan Capital Management Inc
- $2.1 Billion
- Q1 2025
A detailed history of Logan Capital Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Logan Capital Management Inc holds 16 shares of AZN stock, worth $1,225. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16
Previous 16
-0.0%
Holding current value
$1,225
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding AZN
# of Institutions
1,422Shares Held
505MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.37 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$3.11 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.73 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.44 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.4 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $237B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...